{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T03:27:48Z","timestamp":1771039668231,"version":"3.50.1"},"reference-count":53,"publisher":"Bentham Science Publishers Ltd.","issue":"4","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CPB"],"published-print":{"date-parts":[[2019,5,28]]},"abstract":"<jats:sec>\n<jats:title>Background:<\/jats:title>\n<jats:p>The global rise of multi-drug resistant M. tuberculosis demands unconventional\ntreatment to enhance the efficiency of current drugs. Punica granatum, which is known as pomegranate,\nis considered as a member of the Punicaceae family. Pomegranate, which is broadly documented for its\nactivity against a wide spectrum of bacterial pathogens, deserves further scrutiny in this respect.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods:<\/jats:title>\n<jats:p>Within this scope, this study investigated the effect of fresh pomegranate juice (FPJ) on the\nantibacterial activity of anti-tuberculosis drugs (Rifampin (R) and Isoniazid (INH)) against MDR-TB\nclinical isolates. The drug resistance profiles in M. tuberculosis clinical isolates were determined by\nsusceptibility test using BACTEC MGIT 960 system. Four concentrations of fresh pomegranate juice\n(FPJ) (5%, 10%, 15%, and 20%) were evaluated in combination with R and INH at a dose range of\n(1.0 \u00b5g\/ml) and (0.1 \u00b5g\/ml), respectively against the MDR-TB isolates by the BACTEC MGIT 960\nsystem. Moreover, this study scrutinized individual phenolic compounds of FPJ by using highperformance\nliquid chromatography (HPLC). The total polyphenols (TP), total flavonoid (TF), total\nanthocyanins content (TAC), and the antioxidant capacity were also assessed in FPJ.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p>Synergistic effects were observed between R and INH with FPJ against all tested strains.\nHowever, combination therapy of rifampin was more effective than isoniazid one. Therefore, the combination\nof R and FPJ has been used against (27) MDR-TB clinical isolates. 5% of FPJ plus R (1.0\n\u00b5g\/ml) were found to suppress the growth of one isolates for first group (INH and R resistant). However,\n5% of FPJ demonstrated no synergistic impact with R for second (SM, R and INH resistant) and\nthird group (INH, EMB, R and SM resistant). Moreover, 10% of FPJ and R (1.0 \u03bcg\/ml) inhibited the\nbacterial growth of three isolates of first group and two isolates and one isolate for second and third\ngroup, respectively. Remarkably, 15% of FPJ plus R (1.0 \u00b5g\/ml) appeared to inhibit the growth of\nMDR-TB isolates for all tested groups indicating a strong synergistic effect. Regarding H37RV, the\ncomplete inhibition of the bacterial growth was found to occur at 15% and 20% concentrations of FPJ\nonly. Minimum inhibitory concentration (MIC) of FPJ ranged from (4% to13%) for first group and\nfrom (10% to15%) for second and third group. Thus, FPJ at 15% inhibited 100% of bacteria for all\ntested isolates (MIC100% =15%). Phenolic compounds identified in FPJ were gallic acid, benzoic\nacid, syringic, folic acid, pelargonidin, naringin+ellagic acid, naringenin, chlorogenic acid, caffeic\nacid, catechin, myricetin, kaempferol, quercetin, cyanidin-3-glycoside, p-cummaric acid, ferulic acid,\nand rutin. Total phenolic (TP), total flavonoid (TF), and total anthocyanin (TA) content were 841.5 mg\/L,\n638.73 mg RE\/L, and 47.43 mg\/L, accordingly.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p>Overall, FPJ displayed synergistic effect with R against MDR-TB clinical isolates due to\nits high content of polyphenol and antioxidant capability.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1389201020666190308130343","type":"journal-article","created":{"date-parts":[[2019,3,11]],"date-time":"2019-03-11T10:54:03Z","timestamp":1552301643000},"page":"317-326","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Evaluation of Polyphenolic Profile and Antibacterial Activity of Pomegranate Juice in Combination with Rifampin (R) against MDR-TB Clinical Isolates"],"prefix":"10.2174","volume":"20","author":[{"given":"Manaf","family":"AlMatar","sequence":"first","affiliation":[{"name":"Department of Biotechnology, Institute of Natural and Applied Sciences (Fen Bilimleri Enstitusu), Cukurova University, Adana, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I\u015f\u0131l","family":"Var","sequence":"additional","affiliation":[{"name":"Department of Food Engineering, Agricultural Faculty, Cukurova University, Adana, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beg\u00fcm","family":"Kayar","sequence":"additional","affiliation":[{"name":"Department of Medical Microbiology, Faculty of Medicine, Cukurova University, Adana, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emel","family":"Eker","sequence":"additional","affiliation":[{"name":"Department of Medical Microbiology, Faculty of Medicine, Cukurova University, Adana, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ebru","family":"Kafkas","sequence":"additional","affiliation":[{"name":"Department of Horticulture, Faculty of Agriculture, Cukurova University, Adana, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mozhgan","family":"Zarifikhosroshahi","sequence":"additional","affiliation":[{"name":"Department of Horticulture, Faculty of Agriculture, Cukurova University, Adana, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatih","family":"K\u00f6ksal","sequence":"additional","affiliation":[{"name":"Department of Medical Microbiology, Faculty of Medicine, Cukurova University, Adana, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"crossref","first-page":"4302","DOI":"10.1016\/j.fct.2012.09.001","volume":"50","author":"Dey D.","year":"2012","unstructured":"Dey D, Debnath S, Hazra S, Ghosh S, Ray R, Hazra B.  Pomegranate pericarp extract enhances the antibacterial activity of ciprofloxacin against extended-spectrum \u03b2-lactamase (ESBL) and metallo-\u03b2-lactamase (MBL) producing Gram-negative bacilli.","journal-title":"Food Chem Toxicol"},{"key":"ref=2","first-page":"128","volume":"13","author":"Jurenka J.","year":"2008","unstructured":"Jurenka J.  Therapeutic applications of pomegranate ( L.): A review.","journal-title":"Altern Med Rev"},{"key":"ref=3","doi-asserted-by":"crossref","first-page":"M341","DOI":"10.1111\/j.1750-3841.2007.00533.x","volume":"72","author":"Naz S.","year":"2007","unstructured":"Naz S, Siddiqi R, Ahmad S, Rasool S, Sayeed S.  Antibacterial activity directed isolation of compounds from","journal-title":"J Food Sci"},{"key":"ref=4","doi-asserted-by":"crossref","first-page":"507","DOI":"10.2174\/1389557517666170419114722","volume":"18","author":"AlMatar M.","year":"2018","unstructured":"AlMatar M, Islam M, Albari O, Var I, K\u00f6ksal F.  Pomegranate as a possible treatment in reducing risk of developing wound healing, obesity, neurodegenerative disorders, and diabetes mellitus.","journal-title":"Mini Rev Med Chem"},{"key":"ref=5","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1111\/j.1541-4337.2010.00131.x","volume":"9","author":"Viuda-Martos M.","year":"2010","unstructured":"Viuda-Martos M, Fern\u00e1ndez-L\u00f3pez J, P\u00e9rez-\u00c1lvarez J.  Pomegranate and its many functional components as related to human health: A review.","journal-title":"Compr Rev Food Sci Food Saf"},{"key":"ref=6","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1128\/CMR.12.4.564","volume":"12","author":"Cowan M.M.","year":"1999","unstructured":"Cowan MM.  Plant products as antimicrobial agents.","journal-title":"Clin Microbiol Rev"},{"key":"ref=7","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.jep.2006.09.006","volume":"109","author":"Lansky E.P.","year":"2007","unstructured":"Lansky EP, Newman RA.  \n (pomegranate) and its potential for prevention and treatment of inflammation and cancer.","journal-title":"J Ethnopharmacol"},{"key":"ref=8","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.jep.2004.08.034","volume":"96","author":"Braga L.","year":"2005","unstructured":"Braga L, Shupp J, Cummings C, Jett M, Takahashi J, Carmo L, Chartone-Souza E, Nascimento A.  Pomegranate extract inhibits  growth and subsequent enterotoxin production.","journal-title":"J Ethnopharmacol"},{"key":"ref=9","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.ijfoodmicro.2009.07.002","volume":"134","author":"Al-Zoreky N.","year":"2009","unstructured":"Al-Zoreky N.  Antimicrobial activity of pomegranate ( L.) fruit peels.","journal-title":"Int J Food Microbiol"},{"key":"ref=10","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s11947-008-0095-5","volume":"2","author":"Opara L.U.","year":"2009","unstructured":"Opara LU, Al-Ani MR, Al-Shuaibi YS.  Physico-chemical properties, vitamin C content, and antimicrobial properties of pomegranate fruit ( L.).","journal-title":"Food Bioprocess Technol"},{"key":"ref=11","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1021\/jf071811q","volume":"56","author":"Aviram M.","year":"2008","unstructured":"Aviram M, Volkova N, Coleman R, Dreher M, Reddy MK, Ferreira D, Rosenblat M.  Pomegranate phenolics from the peels, arils, and flowers are antiatherogenic: Studies  in atherosclerotic apolipoprotein E-deficient (E0) mice and  in cultured macrophages and lipoproteins.","journal-title":"J Agric Food Chem"},{"key":"ref=12","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.nut.2008.03.013","volume":"24","author":"Shukla M.","year":"2008","unstructured":"Shukla M, Gupta K, Rasheed Z, Khan KA, Haqqi TM.  Consumption of hydrolyzable tannins-rich pomegranate extract suppresses inflammation and joint damage in rheumatoid arthritis.","journal-title":"Nutrition"},{"key":"ref=13","doi-asserted-by":"crossref","first-page":"2488","DOI":"10.1001\/jama.2009.1815","volume":"302","author":"Obeid K.M.","year":"2009","unstructured":"Obeid KM, Saravolatz L.  Tuberculosis: A comprehensive clinical reference.","journal-title":"JAMA"},{"key":"ref=14","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.pharep.2017.09.001","volume":"70","author":"AlMatar M.","year":"2018","unstructured":"AlMatar M, Makky EA, Var I, Kayar B, K\u00f6ksal F.  Novel compounds targeting InhA for TB therapy.","journal-title":"Pharmacol Rep"},{"key":"ref=15","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1016\/S0140-6736(12)60727-2","volume":"379","author":"Raviglione M.","year":"2012","unstructured":"Raviglione M, Marais B, Floyd K, L\u00f6nnroth K, Getahun H, Migliori GB, Harries AD, Nunn P, Lienhardt C, Graham S.  Scaling up interventions to achieve global tuberculosis control: Progress and new developments.","journal-title":"Lancet"},{"key":"ref=16","first-page":"970","volume":"9","author":"Dye C.","year":"2005","unstructured":"Dye C, Scheele S, Dolin P, Pathania V, Raviglione M.  Consensus statement. Global burden of tuberculosis: Estimated incidence, prevalence, and mortality by in an urban community.","journal-title":"Int J Tuberc Lung Dis"},{"key":"ref=17","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1183\/09031936.00205512","volume":"42","author":"Diel R.","year":"2013","unstructured":"Diel R, Loddenkemper R, Zellweger J, Sotgiu G, D\u2019Ambrosio L, Centis R, van der Werf M, Dara M, Detjen A, Gondrie P.  Reichman, L.; Blasi, F.; Migliori, G.B.; European Forum for TB Innovation. Old ideas to innovate TB control: Preventive treatment to achieve elimination.","journal-title":"Eur Respir J"},{"key":"ref=18","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1038\/nrd4001","volume":"12","author":"Zumla A.","year":"2013","unstructured":"Zumla A, Nahid P, Cole ST.  Advances in the development of new tuberculosis drugs and treatment regimens.","journal-title":"Nat Rev Drug Discov"},{"key":"ref=19","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.diagmicrobio.2016.10.023","volume":"87","author":"Adami A.G.","year":"2017","unstructured":"Adami AG, Gallo JF, Pinhata JMW, Martins MC, Giampaglia CMS, de Oliveira RS.  Modified protocol for drug susceptibility testing of MGIT cultures of  by the MGIT 960.","journal-title":"Diagn Microbiol Infect Dis"},{"key":"ref=20","doi-asserted-by":"crossref","first-page":"2934","DOI":"10.1007\/s11947-011-0533-7","volume":"5","author":"Fawole O.A.","year":"2012","unstructured":"Fawole OA, Opara UL, Theron KI.  Chemical and phytochemical properties and antioxidant activities of three pomegranate cultivars grown in South Africa.","journal-title":"Food Bioprocess Technol"},{"key":"ref=21","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/j.foodchem.2010.12.156","volume":"127","author":"Fischer U.A.","year":"2011","unstructured":"Fischer UA, Carle R, Kammerer DR.  Identification and quantification of phenolic compounds from pomegranate ( L.) peel, mesocarp, aril and differently produced juices by HPLC-DAD-ESI\/MSn.","journal-title":"Food Chem"},{"key":"ref=22","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/S0308-8146(98)00102-2","volume":"64","author":"Zhishen J.","year":"1999","unstructured":"Zhishen J, Mengcheng T, Jianming W.  The determination of flavonoid contents in mulberry and their scavenging effects on superoxide radicals.","journal-title":"Food Chem"},{"key":"ref=23","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.foodchem.2008.04.043","volume":"111","author":"Ozgen M.","year":"2008","unstructured":"Ozgen M, Durga\u00e7 C, Ser\u00e7e S, Kaya C.  Chemical and antioxidant properties of pomegranate cultivars grown in the Mediterranean region of Turkey.","journal-title":"Food Chem"},{"key":"ref=24","doi-asserted-by":"crossref","first-page":"4581","DOI":"10.1021\/jf000404a","volume":"48","author":"Gil M.I.","year":"2000","unstructured":"Gil MI, Tom\u00e1s-Barber\u00e1n FA, Hess-Pierce B, Holcroft DM, Kader AA.  Antioxidant activity of pomegranate juice and its relationship with phenolic composition and processing.","journal-title":"J Agric Food Chem"},{"key":"ref=25","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0023-6438(95)80008-5","volume":"28","author":"Brand-Williams W.","year":"1995","unstructured":"Brand-Williams W, Cuvelier M-E, Berset C.  Use of a free radical method to evaluate antioxidant activity.","journal-title":"LWT-Food Sci Technol"},{"key":"ref=26","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1056\/NEJMra0908076","volume":"363","author":"Nathanson E.","year":"2010","unstructured":"Nathanson E, Nunn P, Uplekar M, Floyd K, Jaramillo E, L\u00f6nnroth K, Weil D, Raviglione M.  MDR tuberculosis-critical steps for prevention and control.","journal-title":"New Engl J Med"},{"key":"ref=27","unstructured":"Organization, W.H. Multidrug and extensively drug-resistant TB (M\/XDR-TB): 2010 global report on surveillance and response. Multidrug and extensively drug-resistant TB (M\/XDR-TB): 2010 global report on surveillance and response. 2010 at https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/44286\/9789241599191_eng.pdf;jsessionid=ABDD1897149415F540E098D0C2E808DE?sequence=1 ["},{"key":"ref=28","author":"Kolyva A.S.","year":"2012","unstructured":"Kolyva, A.S.; Karakousis, P.C. Old and new TB drugs: Mechanisms of action and resistance.Understanding Tuberculosis-New Approaches to Fighting Against Drug Resistance; InTech, 2012.","journal-title":"InTech"},{"key":"ref=29","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1099\/0022-1317-51-1-11","volume":"51","author":"Heifets L.","year":"2002","unstructured":"Heifets L.  Susceptibility testing of  to pyrazinamide.","journal-title":"J Med Microbiol"},{"key":"ref=30","doi-asserted-by":"crossref","first-page":"4714","DOI":"10.1128\/JB.00305-09","volume":"191","author":"Vandal O.H.","year":"2009","unstructured":"Vandal OH, Nathan CF, Ehrt S.  Acid resistance in","journal-title":"J Bacteriol"},{"key":"ref=31","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1164\/arrd.1977.116.4.627","volume":"116","author":"Dickinson J.M.","year":"1977","unstructured":"Dickinson JM, Aber V, Mitchison D.  Bactericidal activity of streptomycin, isoniazid, rifampin, ethambutol, and pyrazinamide alone and in combination against","journal-title":"Am Rev Respir Dis"},{"key":"ref=32","doi-asserted-by":"crossref","first-page":"4178","DOI":"10.1128\/AAC.00830-09","volume":"53","author":"Almeida D.","year":"2009","unstructured":"Almeida D, Nuermberger E, Tasneen R, Rosenthal I, Tyagi S, Williams K, Peloquin C, Grosset J.  Paradoxical effect of isoniazid on the activity of rifampin-pyrazinamide combination in a mouse model of tuberculosis.","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=33","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1128\/AAC.36.3.548","volume":"36","author":"Grosset J.","year":"1992","unstructured":"Grosset J, Truffot-Pernot C, Lacroix C, Ji B.  Antagonism between isoniazid and the combination pyrazinamide-rifampin against tuberculosis infection in mice.","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=34","doi-asserted-by":"crossref","first-page":"e00139","DOI":"10.1128\/mBio.00139-10","volume":"1","author":"Drusano G.","year":"2010","unstructured":"Drusano G, Sgambati N, Eichas A, Brown DL, Kulawy R, Louie A.  The combination of rifampin plus moxifloxacin is synergistic for suppression of resistance but antagonistic for cell kill of  as determined in a hollow-fiber infection model.","journal-title":"MBio"},{"key":"ref=35","first-page":"5318","volume":"50","author":"Greco W.R.","year":"1990","unstructured":"Greco WR, Park HS, Rustum YM.  Application of a new approach for the quantitation of drug synergism to the combination of cis-diamminedichloroplatinum and 1-\u03b2-D-arabinofuranosyl-cytosine.","journal-title":"Cancer Res"},{"key":"ref=36","doi-asserted-by":"crossref","first-page":"e101311","DOI":"10.1371\/journal.pone.0101311","volume":"9","author":"Drusano G.L.","year":"2014","unstructured":"Drusano GL, Neely M, Van Guilder M, Schumitzky A, Brown D, Fikes S, Peloquin C, Louie A.  Analysis of combination drug therapy to develop regimens with shortened duration of treatment for tuberculosis.","journal-title":"PLoS One"},{"key":"ref=37","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1128\/AAC.02154-12","volume":"57","author":"Piccaro G.","year":"2013","unstructured":"Piccaro G, Giannoni F, Filippini P, Mustazzolu A, Fattorini L.  Activities of drug combinations against  grown in aerobic and hypoxic acidic conditions.","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=38","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/nrmicro1816","volume":"6","author":"Sacchettini J.C.","year":"2008","unstructured":"Sacchettini JC, Rubin EJ, Freundlich JS.  Drugs versus bugs: in pursuit of the persistent predator","journal-title":"Nat Rev Microbiol"},{"key":"ref=39","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.tube.2010.03.005","volume":"90","author":"Mitchison D.","year":"2010","unstructured":"Mitchison D, Fourie P.  The near future: Improving the activity of rifamycins and pyrazinamide.","journal-title":"Tuberculosis"},{"key":"ref=40","first-page":"6","volume":"7","author":"Zhang Y.","year":"2003","unstructured":"Zhang Y, Mitchison D.  The curious characteristics of pyrazinamide: A review.","journal-title":"Int J Tuberc Lung Dis"},{"key":"ref=41","doi-asserted-by":"crossref","first-page":"27620","DOI":"10.3402\/fnr.v59.27620","volume":"59","author":"Betanzos-Cabrera G.","year":"2015","unstructured":"Betanzos-Cabrera G, Montes-Rubio PY, Fabela-Illescas HE, Belefant-Miller H, Cancino-Diaz JC.  Antibacterial activity of fresh pomegranate juice against clinical strains of","journal-title":"Food Nutr Res"},{"key":"ref=42","doi-asserted-by":"crossref","first-page":"2152749","DOI":"10.1155\/2017\/2152749","volume":"2017","author":"Ferrazzano G.F.","year":"2017","unstructured":"Ferrazzano GF, Scioscia E, Sateriale D, Pastore G, Colicchio R, Pagliuca C, Cantile T, Alcidi B, Coda M, Ingenito A.  \n antibacterial activity of pomegranate juice and peel extracts on cariogenic bacteria.","journal-title":"BioMed Res Int"},{"key":"ref=43","doi-asserted-by":"crossref","first-page":"6300","DOI":"10.1021\/jf070094x","volume":"55","author":"Cristani M.","year":"2007","unstructured":"Cristani M, D\u2019Arrigo M, Mandalari G, Castelli F, Sarpietro MG, Micieli D, Venuti V, Bisignano G, Saija A, Trombetta D.  Interaction of four monoterpenes contained in essential oils with model membranes: Implications for their antibacterial activity.","journal-title":"J Agric Food Chem"},{"key":"ref=44","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1021\/jf073035s","volume":"56","author":"Seeram N.P.","year":"2008","unstructured":"Seeram NP, Aviram M, Zhang Y, Henning SM, Feng L, Dreher M, Heber D.  Comparison of antioxidant potency of commonly consumed polyphenol-rich beverages in the United States.","journal-title":"J Agric Food Chem"},{"key":"ref=45","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1046\/j.1365-2672.1998.00363.x","volume":"84","author":"Ahn Y.J.","year":"1998","unstructured":"Ahn YJ, Lee CO, Kweon JH, Ahn JW, Park JH.  Growth-inhibitory effects of Galla Rhois-derived tannins on intestinal bacteria.","journal-title":"J Appl Microbiol"},{"key":"ref=46","doi-asserted-by":"crossref","first-page":"S2675","DOI":"10.1016\/j.arabjc.2013.10.011","volume":"10","author":"Hmid I.","year":"2017","unstructured":"Hmid I, Elothmani D, Hanine H, Oukabli A, Mehinagic E.  Comparative study of phenolic compounds and their antioxidant attributes of eighteen pomegranate ( L.) cultivars grown in Morocco.","journal-title":"Arab J Chem"},{"key":"ref=47","first-page":"492","volume":"8","author":"Artik N.","year":"1998","unstructured":"Artik N.  Determination of phenolic compounds in pomegranate juice by using HPLC.","journal-title":"Fruit Process"},{"key":"ref=48","doi-asserted-by":"crossref","first-page":"1700699","DOI":"10.1002\/mnfr.201700699","volume":"62","author":"Kosuru R.Y.","year":"2018","unstructured":"Kosuru RY, Roy A, Das SK, Bera S.  Gallic Acid and gallates in human health and disease: Do mitochondria hold the key to success?","journal-title":"Mol Nutr Food Res"},{"key":"ref=49","doi-asserted-by":"crossref","first-page":"Article ID 907101, 7","DOI":"10.1155\/2015\/907101","volume":"2015","author":"Akhavan H.","year":"2015","unstructured":"Akhavan H, Barzegar M, Weidlich H, Zimmermann BF.  Phenolic compounds and antioxidant activity of juices from ten Iranian pomegranate cultivars depend on extraction.","journal-title":"J Chem"},{"key":"ref=50","doi-asserted-by":"crossref","first-page":"5328","DOI":"10.1021\/jf400684n","volume":"61","author":"G\u00f3mez-Caravaca A.M.","year":"2013","unstructured":"G\u00f3mez-Caravaca AM, Verardo V, Toselli M, Segura-Carretero A, Fern\u00e1ndez-Guti\u00e9rrez A, Caboni MF.  Determination of the major phenolic compounds in pomegranate juices by HPLC-DAD-ESI-MS.","journal-title":"J Agric Food Chem"},{"key":"ref=51","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.nutres.2007.12.001","volume":"28","author":"Guo C.","year":"2008","unstructured":"Guo C, Wei J, Yang J, Xu J, Pang W, Jiang Y.  Pomegranate juice is potentially better than apple juice in improving antioxidant function in elderly subjects.","journal-title":"Nutr Res"},{"key":"ref=52","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1080\/10942910903383438","volume":"14","author":"Hasnaoui N.","year":"2011","unstructured":"Hasnaoui N, Jbir R, Mars M, Trifi M, Kamal-Eldin A, Melgarejo P, Hernandez F.  Organic acids, sugars, and anthocyanins contents in juices of Tunisian pomegranate fruits.","journal-title":"Int J Food Prop"},{"key":"ref=53","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.foodchem.2008.06.009","volume":"112","author":"\u00c7am M.","year":"2009","unstructured":"\u00c7am M, H\u0131\u015f\u0131l Y, Durmaz G.  Classification of eight pomegranate juices based on antioxidant capacity measured by four methods.","journal-title":"Food Chem"}],"container-title":["Current Pharmaceutical Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/eurekaselect.com\/article\/download\/170573","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,4]],"date-time":"2019-07-04T15:26:48Z","timestamp":1562254008000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.eurekaselect.com\/170573\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,28]]},"references-count":53,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,5,28]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1389201020666190308130343","relation":{},"ISSN":["1389-2010"],"issn-type":[{"value":"1389-2010","type":"print"}],"subject":[],"published":{"date-parts":[[2019,5,28]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2018-11-25","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-02-11","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-03-05","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-05-28","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}